newsfilter
← Latest News
GlobeNewswire·

Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022

SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced the acceptance of three abstracts on the treatme